Jean-Marie Eveillard - First Eagle Investment Management,
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    418
Portfolio value:    $58,918,305,053
Holdings Activity Buys Sells    History
Holding/activity history for  Corcept Therapeutics Inc (CORT)
Period Shares % of Portfolio Activity % Change to Portfolio Reported Price Value Filing
2016   Q4 0 0.00 Sell 100.00% <0.01 SEC
2016   Q3 125,000 <0.01 Reduce 44.18% <0.01 $6.50 $813,000 SEC
2016   Q2 223,935 <0.01 Reduce 43.40% <0.01 $5.46 $1,223,000 SEC
2016   Q1 395,670 <0.01 Add 31.89% <0.01 $4.68 $1,852,000 SEC
2015   Q4 300,000 <0.01 $4.98 $1,494,000 SEC
2015   Q3 300,000 <0.01 Add 50.00% <0.01 $3.76 $1,128,000 SEC
2015   Q2 200,000 <0.01 Buy <0.01 $6.01 $1,202,000 SEC
2014   Q1 0 0.00 Sell 100.00% 0.01 SEC
2013   Q4 991,978 0.01 Reduce 60.26% <0.01 $3.22 $3,194,000 SEC
2013   Q3 2,496,078 0.01 Reduce 1.61% <0.01 $1.59 $3,969,000 SEC
2013   Q2 2,536,866 0.01 $1.73 $4,389,000 SEC
2013   Q1 2,536,866 0.02 $2.00 $5,074,000 SEC
2012   Q4 2,536,866 0.02 Add 104.30% 0.01 $1.43 $3,628,000 SEC
2012   Q3 1,241,766 0.02 Add 25.21% <0.01 $2.79 $3,465,000 SEC
2012   Q2 991,766 0.02 $4.49 $4,453,000 SEC
2012   Q1 991,766 0.02 Add 11.21% <0.01 $3.93 $3,898,000 SEC
2011   Q4 891,766 0.02 Reduce 1.11% <0.01 $3.42 $3,050,000 SEC
2011   Q3 901,766 0.02 Add 1.41% <0.01 $3.10 $2,795,000 SEC
2011   Q2 889,266 0.02 Reduce 11.51% <0.01 $3.99 $3,548,000 SEC
2011   Q1 1,004,966 0.03 Add 34.77% <0.01 $4.25 $4,271,000 SEC
2010   Q4 745,665 0.01 Reduce 20.57% <0.01 $3.86 $2,878,000 SEC
2010   Q3 938,790 0.03 Add 2.25% <0.01 $3.89 $3,652,000 SEC
2010   Q2 918,175 0.03 Buy 0.03 $3.12 $2,865,000 SEC
2010   Q1 0 0.00 Sell 100.00% 0.01 SEC
2009   Q4 418,175 0.01 $2.78 $1,163,000 SEC
2009   Q3 418,175 0.01 $1.50 $627,000 SEC
2009   Q2 418,175 0.01 Buy 0.01 $0.81 $339,000 SEC
2006   Q4 0 0.00 Sell 100.00% <0.01 SEC
2006   Q3 74,700 <0.01 Add 49.40% <0.01 $0.91 $68,000 SEC
2006   Q2 50,000 <0.01 $4.06 $203,000 SEC